Chemoinformaics analysis of 2-METHYLBUT-3-EN-2-OL
| Molecular Weight | 86.134 | nRot | 1 |
| Heavy Atom Molecular Weight | 76.054 | nRig | 36 |
| Exact Molecular Weight | 86.0732 | nRing | 0 |
| Solubility: LogS | -5.05 | nHRing | 0 |
| Solubility: LogP | 6.683 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 15.8199 |
| nHD | 1 | BPOL | 10.0321 |
| QED | 0.213 |
| Synth | 2.943 |
| Natural Product Likeliness | 0.897 |
| NR-PPAR-gamma | 0.983 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.978 |
| Pgp-sub | 0.112 |
| HIA | 0.126 |
| CACO-2 | -4.993 |
| MDCK | 0.0000263 |
| BBB | 0 |
| PPB | 0.912664 |
| VDSS | 0.418 |
| FU | 0.0937531 |
| CYP1A2-inh | 0.714 |
| CYP1A2-sub | 0.887 |
| CYP2c19-inh | 0.689 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.663 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.045 |
| CYP2d6-sub | 0.938 |
| CYP3a4-inh | 0.222 |
| CYP3a4-sub | 0.149 |
| CL | 3.842 |
| T12 | 0.096 |
| hERG | 0.051 |
| Ames | 0.303 |
| ROA | 0.054 |
| SkinSen | 0.335 |
| Carcinogencity | 0.036 |
| EI | 0.595 |
| Respiratory | 0.175 |
| NR-Aromatase | 0.93 |
| Antiviral | No |
| Prediction | 0.941376 |